Literature DB >> 3297907

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.

P Ginés, V Arroyo, E Quintero, R Planas, F Bory, J Cabrera, A Rimola, J Viver, J Camps, W Jiménez.   

Abstract

To investigate whether paracentesis could be an alternative therapy for ascites, 117 cirrhotics with tense ascites were randomly allocated into two groups. Fifty-eight patients (group 1) were treated with paracentesis (4-6 L/day until disappearance of ascites) and intravenous albumin infusion (40 g after each tap). Fifty-nine patients (group 2) were treated with spironolactone (200-400 mg/day) plus furosemide (40-240 mg/day). Patients from group 2 not responding to diuretics were treated with a LeVeen shunt. After disappearance of ascites, patients from both groups were discharged from hospital and were instructed to take diuretics. Patients developing tense ascites during follow-up were readmitted to hospital and treated according to their initial schedule. Paracentesis was effective in eliminating the ascites in 56 patients from group 1 (96.5%) and did not induce significant changes in renal and hepatic function, plasma volume, cardiac index, peripheral resistance, plasma renin activity, plasma norepinephrine and antidiuretic hormone concentration, and urinary excretion of prostaglandin E2 and 6-keto-prostaglandin F1 alpha. Diuretics were effective in eliminating the ascites in 43 patients from group 2 (72.8%) (p less than 0.05). Ten patients in group 1 and 36 in group 2 developed complications during their first hospital stay (p less than 0.001). This difference was due to the significantly higher incidence of hepatic encephalopathy, renal impairment, and electrolyte disturbances occurring in patients treated with diuretics. The duration of hospital stay was 11.7 +/- 1.5 days for patients from group 1 and 31 +/- 2.8 days for patients from group 2 (p less than 0.001). The two groups did not differ significantly with respect to the probability of requiring readmission to hospital during follow-up, reasons for readmission, survival probability after entry into the study, and causes of death. These results indicate that paracentesis associated with intravenous albumin infusion is a fast, effective, and safe therapy for ascites in patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297907     DOI: 10.1016/0016-5085(87)91007-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  58 in total

1.  Two cases of refractory ascites associated with dill pickle ingestion.

Authors:  T R Riley
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 2.  Treatment and management of ascites and hepatorenal syndrome: an update.

Authors:  Kurt Lenz; Robert Buder; Lisbeth Kapun; Martin Voglmayr
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

3.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

4.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

5.  Pressure of intraoesophageal varices assessed by fine needle puncture: its relation to endoscopic signs and severity of liver disease in patients with cirrhosis.

Authors:  G Kleber; T Sauerbruch; G Fischer; G Paumgartner
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

Review 6.  Pathophysiology and management of pediatric ascites.

Authors:  Mahmoud Sabri; Miguel Saps; John M Peters
Journal:  Curr Gastroenterol Rep       Date:  2003-06

7.  Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.

Authors:  L Rossaro; A Graziotto; S Bonato; M Plebani; D H van Thiel; A Burlina; R Naccarato; M Salvagnini
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

8.  Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Authors:  Christopher M Moore; David H Van Thiel
Journal:  World J Hepatol       Date:  2013-05-27

Review 9.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

10.  MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.

Authors:  Maria-Carlota Londoño; Andrés Cárdenas; Mónica Guevara; Llorenç Quintó; Dara de Las Heras; Miguel Navasa; Antoni Rimola; Juan-Carlos Garcia-Valdecasas; Vicente Arroyo; Pere Ginès
Journal:  Gut       Date:  2007-04-23       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.